A common drug combo for Parkinson’s disease will require a new FDA warning after the agency flagged 14 cases of seizures in ...

Amid an outpouring of pharma investment dollars into China, Novartis is the latest multinational drugmaker lining up to ...

On top of the newly approved lung disorder pill Brinsupri, which Insmed expects will achieve blockbuster sales this year, the New Jersey company has revealed results from a trial of its older lung ...

Watch out, Johnson & Johnson. Dizal has reported positive phase 3 results for its oral Zegfrovy that could put more pressure ...

Since its introduction nine months ago, the FDA’s national priority voucher pilot program has attracted intrigue and fierce ...

As pharmaceutical companies face increasing pressure to produce more content across more channels, the Medical, Legal, and ...

Johnson & Johnson and Protagonist Therapeutics are countering the swarm of injectable biologics that have long dominated the ...

It’s time once again for Fierce Pharma Marketing’s annual #FierceMadness tournament. This time around, we're watching 64 ...

Some three weeks into the U.S. and Israel’s war with Iran, the expanding conflict’s impact on energy prices and shipping in ...

With patents expiring today in India for Novo Nordisk’s popular diabetes and obesity drugs Ozempic and Wegovy, more than 40 ...

The last available hemophilia gene therapy is temporarily unavailable, according to CSL Behring.  | The company is working ...

Since investment bank HSBC downgraded the stock of Eli Lilly from “hold” to “reduce” on Tuesday morning, the share price of ...